An unusual rock formation highlights the daily worry of extreme swelling for HAE patients in Takeda's awareness campaign. (Image: Discover HAE website)
April 8, 2024 12:56 PM EDT
Pharma
Marketing

Take­da ex­tends rare dis­ease aware­ness cam­paign with pa­tient-in­spired im­agery, sto­ries

Beth Snyder Bulik

Senior Editor

Take­da is con­tin­u­ing to high­light the un­pre­dictable bur­den of hered­i­tary an­gioede­ma in its “Dis­cov­er HAE” cam­paign, in­cor­po­rat­ing more per­son­al sto­ries and im­agery that re­flect pa­tient …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times